IKK16 reduces MLN4924-induced VCaP apoptosis
Cell-based study · Human VCaP prostate cancer cells in medium supplemented with 10% charcoal-stripped serum. [3]
IKK16 at 2 μM reduced apoptosis induced by 500 nM MLN4924 over 5 days. The result is a combination-dependent protective response in this model, not evidence of IKK16 monotherapy killing.
| Endpoint | Reported result | Reference |
|---|---|---|
| Fraction of cells scored apoptotic by caspase-3/7 signal | qualitative response IKK16 reduced the MLN4924-induced apoptotic fraction at 500 nM MLN4924 versus MLN4924 without IKK16. | [3] |
Literature-Reported Treatment Conditions
- Treatment concentration
- IKK16 2 μM; MLN4924 0, 50 or 500 nM in Figure 5c.
- Exposure duration
- 5 days
- Method
- Cell treatment; caspase-3/7 CellEvent fluorescence with Hoechst-based nuclear segmentation.
- Vehicle
- 0.5% DMSO final; 0.5% DMSO control in SI Chemical inhibitor screening.
- Co-treatment
- MLN4924 (MLN), especially 500 nM for the stated apoptosis reduction.
- Reported limits
- Independent biological experiment count for Figure 5c is not specified in the located figure/methods. SI general data quantification mentions four well replicates, whereas chemical inhibitor screening states triplicates; neither is relabeled biological n.
Methods and source locations
Compound reported in the paper: IKK-16; Compound label in the paper: IKK16
Research findings for the material identified as IKK-16 in this publication; no A12836 lot validation or salt-equivalence claim.
Results: CRL inhibition globally affects cell signaling and transcription; Figure 5c and caption; main Apoptosis assay; SI pp. 2–4, 7 and Table S5 p. 28.
Fraction of cells scored apoptotic by caspase-3/7 signal: CellEvent Caspase-3/7 Green reagent and Hoechst segmentation; boxplots. SI statistical section specifies two-sided Wilcoxon rank-based test. Exact fractions are not inferred from the plot. — Figure 5c and caption; Results CRL inhibition globally affects cell signaling and transcription; SI Apoptosis assay, Data quantification and Chemical inhibitor screening.